PMID- 1922933 OWN - NLM STAT- MEDLINE DCOM- 19911031 LR - 20190701 IS - 0304-3940 (Print) IS - 0304-3940 (Linking) VI - 126 IP - 2 DP - 1991 May 27 TI - 2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicity. PG - 191-4 AB - Excitatory amino acid (EAA)-induced cell death in the striatum is dependent upon intact glutamatergic afferents arising from the cerebral cortex. Through a mechanism possibly related to inhibition of glutamate release, adenosine receptor agonists attenuate EAA induced toxicity in the rat striatum. In the present study, we examined whether 2-chloroadenosine (2CLA), a stable adenosine analog, protects against toxicity induced by kainate (KA), quisqualate (QUIS), N-methyl-D-aspartate (NMDA), and ibotenate (IBO). In vivo intrastriatal injections of 2CLA (50 nmol) with each EAA tested provided a partial but significant protective effect versus injection of the EAA alone, as measured by striatal concentrations of gamma-aminobutyric acid (GABA) and substance P-like immunoreactivity (SP-LI). These results show that 2CLA attenuates both NMDA- and non-NMDA-mediated neuronal cell death. FAU - Finn, S F AU - Finn SF AD - Neurochemistry Laboratory, Massachusetts General Hospital, Boston 02114. FAU - Swartz, K J AU - Swartz KJ FAU - Beal, M F AU - Beal MF LA - eng GR - NINDS 16367/DS/DS NIH HHS/United States GR - NS 10828-14A/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 146-77-0 (2-Chloroadenosine) RN - 6384-92-5 (N-Methylaspartate) RN - 8OC22C1B99 (Quisqualic Acid) RN - SIV03811UC (Kainic Acid) SB - IM MH - 2-Chloroadenosine/*pharmacology MH - Animals MH - Corpus Striatum/*drug effects/pathology MH - Injections MH - Kainic Acid/antagonists & inhibitors/*toxicity MH - Male MH - N-Methylaspartate/antagonists & inhibitors/*toxicity MH - Quisqualic Acid/antagonists & inhibitors/*toxicity MH - Rats MH - Rats, Inbred Strains EDAT- 1991/05/27 00:00 MHDA- 1991/05/27 00:01 CRDT- 1991/05/27 00:00 PHST- 1991/05/27 00:00 [pubmed] PHST- 1991/05/27 00:01 [medline] PHST- 1991/05/27 00:00 [entrez] AID - 0304-3940(91)90551-4 [pii] AID - 10.1016/0304-3940(91)90551-4 [doi] PST - ppublish SO - Neurosci Lett. 1991 May 27;126(2):191-4. doi: 10.1016/0304-3940(91)90551-4.